CSIMarket
 


Salarius Pharmaceuticals inc   (SLRX)
Other Ticker:  
 

Salarius Pharmaceuticals Inc 's Leverage Ratio

SLRX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -34.75% Salarius Pharmaceuticals Inc improved Leverage Ratio in third quarter 2023 to 0.64, above the Salarius Pharmaceuticals Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 221 other companies have achieved lower Leverage Ratio than Salarius Pharmaceuticals Inc in the III Quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the second quarter 2023 from 929 to 975 .

Explain Leverage Ratio?
Who are SLRX Customers?
What are SLRX´s Total Liabilities?


SLRX Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -63.38 % -72.76 % -83.36 % -73.18 % -61.05 %
Y / Y Total Liabilities Change -19.86 % 216.23 % 370.43 % 237.51 % 274.5 %
Leverage Ratio MRQ 0.64 0.7 1.44 0.69 0.29
SLRX's Total Ranking # 975 # 929 # 1654 # 1421 # 739
Seq. Equity Change -27.69 % 51.36 % -46.47 % -37.49 % -46.21 %
Seq. Total Liabilities Change -34.75 % -25.96 % 12.39 % 47.6 % 157.47 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 222
Healthcare Sector # 425
Overall Market # 975


Leverage Ratio Statistics
High Average Low
1.44 0.17 0.01
(Mar 31 2023)   (Mar 31 2015)




Financial Statements
Salarius Pharmaceuticals Inc 's Equity $ 6 Millions Visit SLRX's Balance sheet
Salarius Pharmaceuticals Inc 's Total Liabilities $ 4 Millions Visit SLRX's Balance sheet
Source of SLRX's Sales Visit SLRX's Sales by Geography


Cumulative Salarius Pharmaceuticals Inc 's Leverage Ratio

SLRX's Leverage Ratio for the trailling 12 Months

SLRX Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -63.38 % -72.76 % -83.36 % -73.18 % -61.05 %
Y / Y Total Liabilities TTM Growth -19.86 % 216.23 % 370.43 % 237.51 % 274.5 %
Leverage Ratio TTM 0.82 0.63 0.34 0.17 0.09
Total Ranking TTM # 12 # 1279 # 2 # 3 # 2
Seq. Equity TTM Growth -27.69 % 51.36 % -46.47 % -37.49 % -46.21 %
Seq. Total Liabilities TTM Growth -34.75 % -25.96 % 12.39 % 47.6 % 157.47 %


On the trailing twelve months basis Despite of the repayements of liabilities of -34.75% in the trailing twelve months ending in III Quarter 2023, Leverage Ratio improved to 0.82, above Salarius Pharmaceuticals Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry SLRX recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 12, from total ranking in previous 12 month period at 1279.

Explain Leverage Ratio?
Who are SLRX Customers?
What are SLRX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 2
Within the Market # 12


trailing twelve months Leverage Ratio Statistics
High Average Low
0.04 0.02 0
(Dec 31 2019)   (Dec 31 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Cv Sciences Inc   1.74 $ 6.061  Millions$ 3.479  Millions
Blue Water Biotech Inc   1.72 $ 17.645  Millions$ 10.236  Millions
Emergent Biosolutions Inc   1.72 $ 1,195.900  Millions$ 697.200  Millions
Flora Growth Corp   1.70 $ 22.365  Millions$ 13.122  Millions
Alimera Sciences Inc   1.68 $ 81.943  Millions$ 48.840  Millions
Soligenix inc   1.65 $ 6.963  Millions$ 4.221  Millions
Promis Neurosciences inc   1.65 $ 11.121  Millions$ 6.755  Millions
Catalent Inc   1.61 $ 6,182.000  Millions$ 3,841.000  Millions
Amphastar Pharmaceuticals Inc   1.60 $ 949.493  Millions$ 595.140  Millions
Enveric Biosciences Inc   1.59 $ 3.883  Millions$ 2.436  Millions
Maia Biotechnology Inc   1.55 $ 4.253  Millions$ 2.748  Millions
Rani Therapeutics Holdings Inc   1.52 $ 52.883  Millions$ 34.819  Millions
China Pharma Holdings Inc   1.51 $ 9.241  Millions$ 6.111  Millions
Societal Cdmo Inc   1.51 $ 87.904  Millions$ 58.257  Millions
Avid Bioservices Inc   1.48 $ 270.967  Millions$ 183.675  Millions
Rockwell Medical inc   1.44 $ 31.088  Millions$ 21.518  Millions
Vaxxinity Inc   1.42 $ 33.774  Millions$ 23.705  Millions
Mirum Pharmaceuticals Inc   1.42 $ 381.561  Millions$ 269.081  Millions
Sonoma Pharmaceuticals Inc   1.40 $ 7.960  Millions$ 5.675  Millions
Merck and Co Inc   1.38 $ 57,120.000  Millions$ 41,300.000  Millions
Oncotelic Therapeutics Inc   1.38 $ 16.648  Millions$ 12.086  Millions
Viatris Inc   1.34 $ 27,877.000  Millions$ 20,865.600  Millions
Pds Biotechnology Corp  1.34 $ 32.704  Millions$ 24.484  Millions
Elicio Therapeutics Inc   1.33 $ 17.701  Millions$ 13.286  Millions
Atreca inc   1.33 $ 14.302  Millions$ 10.759  Millions
Liquidia Corporation  1.33 $ 63.635  Millions$ 48.006  Millions
Lucy Scientific Discovery Inc   1.32 $ 3.564  Millions$ 2.702  Millions
Arvinas Inc   1.31 $ 601.100  Millions$ 457.200  Millions
Carisma Therapeutics Inc   1.31 $ 60.486  Millions$ 46.298  Millions
Transcode Therapeutics Inc   1.30 $ 5.788  Millions$ 4.440  Millions

Date modified: 2023-11-12T05:33:30+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com